Life Science Success

Send us a textThis week on the Life Science Success podcast my guest is Tom Denison. His passion is mentoring, advising, and funding biotech startups. He has engaged with over 200+ startups, at all stages, from concept to exit. Tom is the Founder and Chief Relationship Officer of SmartHealth Catalyzer, the hub for Midwest Biotech Venture Creation.

Send us a textWe discuss her journey from passionate Scientist to an inventor to entrepreneur. In her newest venture, she is helping new science become transformative therapeutics. Elaine is a cutting-edge Life Science leader helping companies become a reality from Oaklahoma.

Send us a textIn this interview, I speak with Laura Prisc the Most Trusted Authority on Conscious Leadership for High-Performance Organizations. For more than 20 years, she's worked side-by-side with leaders at all levels in organizations of every size imaginable, from one-location operations through the full continuum of multi-site global organizations.

Send us a textThis week on the podcast I interview Jacob Glanville, PhD we discuss Jacob's journey that led him to Distributed Bio then to Centivax and his work on the Netflix show Pandemic. Jacob Glanville is a serial entrepreneur and computational immuno-engineer. He built and sold his first company Distributed Bio from founding in March of 2012 to a 104M dollar sale to Charles River Laboratories in December of 2020. During that period, he developed the core business model, the research teams, and the technologies that enabled Distributed Bio to become profitable without investment. As part of the acquisition agreement, he founded Centivax Inc and spun out his assets in COVID-19 therapeutics, broad-spectrum vaccines, antivenom antibodies, anti-wound pathogen antibodies, anti-CXCR5 autoimmunity therapeutics, and blood-brain barrier translation technologies into Centivax, where he is now CEO.

Send us a textThis week's guest is Dave Bjork the Research Evangelist. He is a Patient Advocate, Lung Cancer Survivor, Speaker and Advisor. His career spans more than 20 years of progressive experience in nonprofit marketing, patient advocacy and fundraising leadership roles including Vice President of Development, National Foundation for Cancer Research, Bethesda, MD. In this role, He launched several fundraising and advocacy programs and became known as the “Cancer Research Evangelist” because of his dedication and commitment to basic scientific research. He also hosts the Research Evangelist Podcast.    

Send us a textIn this interview, I have the tremendous opportunity to speak with Preveen Ramamoorthy PhD of Regenerative Medical Solutions. We talk about his journey from India to Clemson and the work that he is currently doing with Regenerative Medical Solutions. His current work on Type I and Type II diabetes and his work at the University of Colorado Denver. 

Send us a textIn this episode, I interview Debora Barton, MD, and we discuss Carisma Therapeutics (CAR-T, CAR-M, Macrophage, and Cancer Therapies) as well as her new board role at Tigerlily Foundation.

Send us a textIn this week's podcast, I interview Neil Sankar and we talk about his work in helping teams bring cancer therapies to market. He has worked at the National Cancer Institute and for the past 20 years has been working with large and small pharmaceutical companies that are trying to bring drugs to market. His experience spans small molecules, biologics, and antibody-drug conjugates used in the treatment of advanced tumors. Our conversation covers elements of his 20-year career, leaders he would most like to have a conversation with, and what led him to his career in oncology.

Send us a textThis week on the podcast my guest is Chris Conley.  Chris is the founder of DNA consulting.  In her interactions with Life Sciences companies, she leverages her network to help her clients get things done from bench science to launched product.  

Send us a textIn this episode, I interview Francesco Salituro Independent Consultant at Salituro MedChem Solutions. Francesco has a tremendous background in drug development and he is helping a lot of early-stage companies. Additionally, Frank has supported the Epilepsy Foundation of New England for years because of his son Joseph. Joseph passed away from SUDEP (Sudden Unexplained Death in Epilepsy) which initiated the creation of Joseph's HOPE (Helping Other People with Epilepsy) Scholarship Fund. We discuss Francesco's career, drug discovery and his active life in the Epilepsy Foundation of New England after the loss of his son, in this episode.